- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03963934
Feasibility of a Program on a Nurse-led Telephone 6-month-follow-up for Uncontrolled Hypertensive Women (PreDynamiques)
October 17, 2019 updated by: Central Hospital, Nancy, France
Feasibility of a Program on a Nurse-led Telephone 6-month-follow-up for Uncontrolled Hypertensive Women: a Patient-tailored Intervention
This study evaluate the feasibility of a 6-month personalized support program for hypertensive and non-observant women, led by nurses by telephone follow-up.
Study Overview
Status
Unknown
Conditions
Detailed Description
The program includes 2 themes:
- "Realizing my blood pressure self-measurement" according to the recommendations
- "Optimizing my compliance": understand the antihypertensive treatment, identify the brakes and the levers when taking medication, organize the treatment taking
Visits :
Inclusion visit :
- Collection of consent by the nurse
- Verification of inclusion and non-inclusion criteria : measurement of compliance with a scale for each antihypertensive treatment and BP measurement
- Data collection and goal setting
- Urine collection for dosing anti-hypertension drugs
- Delivery of the schedule of telephone visits that were determined with the patient
Implementation of personalized support with the following steps :
- Data collection : evaluate knowledge and its potential as a patient, identify his needs
- Determination of objectives : define the objectives of the program in each theme with the patient according to the collection of data Implementation of personalized support
- 7 telephone interviews of 20 to 30 minutes use of specific teaching tools and materials by thematic assessment of achievements, validation of objectives
Evaluation of the accompaniment:
- assessment at the final visit
- Final visit at 6-month : Same as the inclusion visit with assessment of the support and questionnaire to assess the patient satisfaction level.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 79 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Woman ≥ 18 to 79 years old,
- Hypertensive and treated with antihypertensive drug(s)
- Unsatisfactory compliance for at least one of her antihypertensive treatment with a score below 80% at the medication adherence scale
- Uncontrolled Blood Pressure (BP) : systolic BP equals to ou greater than140 and / or diastolic BP equals to ou greater than 90 mmHg at inclusion visit
- Inform consent signed
- Affiliation to a French social security scheme or beneficiary of such a scheme
Exclusion Criteria:
- Patient with a history of cardio or cerebrovascular disease in the last 6 months (Stroke or Transient Ischemic Attack, myocardial infarction, heart failure)
- Patient with kidney failure requiring dialysis
- Patient with cognitive pathology: dementia, ... etc.
- Patient with type I diabetes
- Unreachable patient by phone or foreseeable inability or unwillingness to comply with study follow-up
- Patient who does not understand and does not speak French
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Women with uncontrolled hypertension
Women with uncontrolled hypertension and unsatisfactory medication adherence
|
Implementation of personalized support: The accompaniment includes 7 telephone interviews for 6 months (understanding the antihypertensive treatment, identifying the brakes and the levers when taking medication, organizing the treatment taking, making the home blood pressure)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of women who completed all telephone follow-ups and came to the final visit at 6 months.
Time Frame: 6 months
|
The goal of recruitment in 6 months will be 20 women and the goal of the program finalization will be of at least 80% of patients (16 patients).
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Edith DAUCHY, RN, CHRU Nancy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 1, 2019
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
June 1, 2021
Study Registration Dates
First Submitted
May 23, 2019
First Submitted That Met QC Criteria
May 24, 2019
First Posted (Actual)
May 28, 2019
Study Record Updates
Last Update Posted (Actual)
October 21, 2019
Last Update Submitted That Met QC Criteria
October 17, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-A01921-56
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arterial Hypertension
-
Vanderbilt University Medical CenterJohns Hopkins UniversityCompletedPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial HypertensionUnited States
-
National Institute of Cardiology, Laranjeiras,...CompletedArterial Hypertension | Resistant Arterial HypertensionBrazil
-
Klinikum Wels-GrieskirchenEuropean Regional Development Fund; Austrian Society of Hypertension; I.E.M....CompletedSuspected Arterial HypertensionSwitzerland, Austria, Germany, Greece, Italy, Spain, United Kingdom
-
Heart Center Leipzig - University HospitalCompletedTherapy Resistant Arterial HypertensionGermany
-
ActelionRecruitingArterial Hypertension, PulmonaryPoland, Germany
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and DevelopmentUnknown
-
Novartis PharmaceuticalsCompletedSevere Pulmonary Arterial HypertensionJapan
-
Association de Recherche en Physiopathologie RespiratoireGlaxoSmithKline; Soladis; InterlisUnknownPulmonary Arterial Hypertension (PAH)France
-
Medical University of GrazLudwig Boltzmann Institute for Lung Vascular ResearchCompletedIdiopathic Pulmonary Arterial HypertensionAustria
-
Zhejiang UniversityCompletedIdiopathic Pulmonary Arterial HypertensionChina